Physician profile
Scott D Robertson
NPI 1376553875
$19,920.56
in general payments reported to CMS, 2019-2025
69 companies · $2,719 in 2025
The $2,719 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,770 · 2020: $1,805 · 2021: $3,432 · 2022: $3,745 · 2023: $2,872 · 2024: $2,578 · 2025: $2,719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,168.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,275.61 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $2,172.31 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,898.29 | 2019-2025 | Airsupra, Farxiga, Flumist Quadrivalent |
| Lilly USA, LLC | $1,302.47 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,270.39 | 2020-2025 | Jardiance, Synjardy, Tradjenta |
| Glaxosmithkline, LLC. | $1,257.10 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $1,176.03 | 2019-2025 | Repatha, Evenity, Prolia |
| Janssen Pharmaceuticals, INC | $1,169.40 | 2019-2024 | Xarelto, Spravato |
| Pfizer INC. | $807.35 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $518.71 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Novartis Pharmaceuticals Corporation | $383.88 | 2019-2025 | |
| Allergan, INC. | $352.72 | 2019-2020 | |
| Amarin Pharma, INC. | $316.58 | 2019-2022 | |
| Corcept Therapeutics | $304.95 | 2022-2025 | Korlym |
| Biohaven Pharmaceutical Holding Company LTD. | $278.91 | 2022 |
Show all 69 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $278.32 | 2020-2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $260.03 | 2021-2025 | |
| Phathom Pharmaceuticals, INC. | $251.66 | 2024-2025 | Voquezna |
| Kowa Pharmaceuticals America, INC. | $249.37 | 2019-2025 | Zoryve, Seglentis, Livalo |
| Astellas Pharma US INC | $182.34 | 2020-2024 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $175.97 | 2019-2025 | Trintellix |
| Radius Health, INC. | $168.21 | 2019-2025 | Tymlos |
| Xeris Pharmaceuticals, INC. | $165.94 | 2022-2025 | Gvoke Hypopen |
| Teva Pharmaceuticals USA, INC. | $159.76 | 2020-2023 | Airduo Digihaler |
| Sanofi-Aventis U.S. LLC | $144.63 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $138.75 | 2019-2025 | Eliquis |
| Esperion Therapeutics, INC. | $126.94 | 2020-2025 | Nexletol |
| Eisai INC. | $120.02 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $113.32 | 2022-2025 | Caplyta |
| Aerin Medical INC. | $110.63 | 2019 | |
| Exact Sciences Corporation | $104.01 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Recordati_rare_diseases_inc. | $103.01 | 2025 | Isturisa |
| Otsuka America Pharmaceutical, INC. | $97.82 | 2024-2025 | Rexulti |
| Biohaven Pharmaceuticals, INC. | $94.58 | 2021 | |
| Hologic Sales and Service, LLC | $89.11 | 2022-2024 | Aptima, Thinprep 2000 Processor |
| Abbott Laboratories | $83.43 | 2022-2025 | Freestyle Libre 3 |
| Ardelyx, INC. | $82.34 | 2024 | Ibsrela |
| Almatica Pharma LLC | $79.68 | 2023-2024 | Loreev Xr |
| Supernus Pharmaceuticals, INC. | $73.78 | 2019-2022 | |
| Sanofi Pasteur INC. | $70.25 | 2020-2024 | |
| Dexcom, INC. | $64.60 | 2019-2024 | Dexcom G6 Transmitter |
| Arbor Pharmaceuticals, INC. | $63.71 | 2021-2022 | |
| Redhill Biopharma INC. | $61.85 | 2020 | |
| Uswm, LLC | $60.67 | 2021-2023 | Lucemyra, Zimhi |
| Indivior INC. | $58.38 | 2022-2025 | Sublocade |
| Horizon Therapeutics Plc | $53.63 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $47.33 | 2025 | Gemtesa |
| Idorsia Pharmaceuticals US INC | $43.83 | 2022-2025 | Quviviq |
| Braeburn INC. | $35.23 | 2025 | Brixadi |
| Amneal Pharmaceuticals LLC | $33.92 | 2021-2022 | |
| Vivus LLC | $33.36 | 2019 | |
| Cranial Technologies, INC | $30.62 | 2019-2024 | Doc Band |
| Inspire Medical Systems, INC. | $28.12 | 2024 | Inspire |
| Bausch Health US, LLC | $27.25 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $24.39 | 2023 | Strensiq |
| Kyowa Kirin, INC. | $22.87 | 2024 | Crysvita |
| Avanir Pharmaceuticals, INC. | $22.17 | 2022 | |
| Seqirus USA INC | $20.56 | 2024 | Fluad |
| Edwards Lifesciences Corporation | $20.20 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $19.22 | 2021 | |
| Ibsa Pharma INC. | $19.16 | 2025 | Flector, Licart, Tirosint |
| Pear Therapeutics (US), INC. | $17.27 | 2022 | |
| Boston Scientific Corporation | $16.25 | 2019 | |
| Itamar Medical INC | $16.03 | 2025 | Watchpatone |
| Genentech USA, INC. | $14.98 | 2019 | |
| Medtronic Minimed, INC. | $14.91 | 2020 | |
| Neos Therapeutics, LP | $14.17 | 2019 | |
| Circassia INC. | $14.17 | 2019 | |
| Azurity Pharmaceuticals, INC. | $13.11 | 2023 | Edarbi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.